Kristin Peck is executive vice president and president of U.S. Operations at Zoetis. In this role, she oversees the management of the livestock and companion animal businesses in the United States. Previously, Ms. Peck was group president at Zoetis. In this role, she was responsible for Global Manufacturing and Supply, Global Poultry, Global Diagnostics, Corporate Development and New Product Marketing and Global Market Research. In this role she led the Zoetis Supply Network Strategy, the Zoetis Digital Strategy and the acquisition of Abbott Animal Health. Ms. Peck is a member of the Advisory Board for the Deming Center for Quality, Productivity and Competitiveness at Columbia Business School. Before joining Zoetis, Ms. Peck served as executive vice president, Worldwide Business Development and Innovation at Pfizer Inc. and as a member of Pfizer's Executive Leadership Team. In this role, she was responsible for Pfizer's merger and acquisition, licensing, venture capital, alliance management and innovative business model activities. She was also responsible for the evaluation of strategic alternatives for Pfizer's Animal Health and Nutrition businesses. Prior to joining Pfizer, Ms. Peck focused on strategy and merger-related issues in the pharmaceutical and financial services industries at the Boston Consulting Group (BCG). She began her career in private equity and real estate finance at The Prudential Realty Group, The O'Connor Group and J.P. Morgan. Ms. Peck is a member of the Thomson Reuters’ Board of Directors and serves on the Human Resources Committee. In addition, she is a member of the Advisory Board for the Deming Center for Quality, Productivity and Competitiveness at Columbia Business School. Ms. Peck holds a Bachelor's degree from Georgetown University and a Master of Business Administration from Columbia Business School.